Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
Background Treatment with immune checkpoint inhibitors (ICIs) has been associated with an increased rate of cardiac events. There are limited data on the risk factors that predict cardiac events in patients treated with ICIs. Therefore, we created a machine learning (ML) model to predict cardiac eve...
Saved in:
| Main Authors: | Tomas G Neilan, Judith Mueller, Samuel Peter Heilbroner, Reed Few, Jitesh Chalwa, Francois Charest, Somasekhar Suryadevara, Christine Kratt, Andres Gomez-Caminero, Brian Dreyfus |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/10/e002545.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors
by: Juan I. Ruiz, et al.
Published: (2025-04-01) -
Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis
by: Asma Dilawari, et al.
Published: (2025-05-01) -
Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitors
by: Michael Sayer, et al.
Published: (2025-04-01) -
Correction: Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
Published: (2021-10-01) -
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
by: Anju Nohria, et al.
Published: (2019-02-01)